Page 3 - Atxs News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Atxs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Atxs Today - Breaking & Trending Today
By Ben Glickman Shares of Astria Therapeutics rose after the company secured a licensing deal for a potential treatment of atopic dermatitis. The stock was. ....
Altium Capital Management LP lowered its position in shares of Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) by 1.2% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,347,088 shares of the biotechnology company’s stock after selling 15,984 shares during the period. […] ....
Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) was the recipient of a large decline in short interest in the month of July. As of July 31st, there was short interest totalling 1,030,000 shares, a decline of 18.3% from the July 15th total of 1,260,000 shares. Currently, 3.7% of the shares of the company are […] ....
Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) saw a significant decrease in short interest in the month of July. As of July 31st, there was short interest totalling 1,030,000 shares, a decrease of 18.3% from the July 15th total of 1,260,000 shares. Based on an average daily volume of 256,800 shares, the short-interest ratio […] ....
Astria Therapeutics (NASDAQ:ATXS – Get Free Report) and Harmony Biosciences (NASDAQ:HRMY – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, profitability, valuation and institutional ownership. Risk and Volatility Astria Therapeutics has a […] ....